17-7260947-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7
The NM_001307.6(CLDN7):c.262C>T(p.Leu88Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00033 in 1,613,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001307.6 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLDN7 | NM_001307.6 | c.262C>T | p.Leu88Leu | synonymous_variant | 2/4 | ENST00000360325.11 | NP_001298.3 | |
CLDN7 | NM_001185022.2 | c.262C>T | p.Leu88Leu | synonymous_variant | 3/5 | NP_001171951.1 | ||
CLDN7 | NM_001185023.2 | c.262C>T | p.Leu88Leu | synonymous_variant | 2/3 | NP_001171952.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLDN7 | ENST00000360325.11 | c.262C>T | p.Leu88Leu | synonymous_variant | 2/4 | 1 | NM_001307.6 | ENSP00000353475.7 | ||
ENSG00000262302 | ENST00000577138.1 | n.223+874C>T | intron_variant | 3 | ENSP00000460571.1 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000232 AC: 58AN: 250280Hom.: 0 AF XY: 0.000207 AC XY: 28AN XY: 135418
GnomAD4 exome AF: 0.000318 AC: 465AN: 1461256Hom.: 0 Cov.: 33 AF XY: 0.000314 AC XY: 228AN XY: 726990
GnomAD4 genome AF: 0.000447 AC: 68AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74382
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at